Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Liu: Leptin activation of corticosterone production in hepatocytes may contribute to the.... (0.10 sec) 

Leptin activation of corticosterone production in hepatocytes may contribute to the …

- diabetesjournals.org
Y Liu, Y Nakagawa, Y Wang, R Li, X Li, T Ohzeki, TC … - Diabetes, 2003 - Am Diabetes Assoc
Glucocorticoids have been implicated as pathophysiological mediators of obesity and insulin
resistance and are regulated by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). This
enzyme regenerates active corticosterone from inactive 11-keto forms. To assess the role ...
Cited by 38 - Related articles - BL Direct - All 7 versions

Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of …

- aspetjournals.org
DEW Livingstone, BR Walker - Journal of Pharmacology and Experimental …, 2003 - ASPET
In liver and adipose tissue, 11 -hydroxysteroid dehydrogenase type 1 (11 -HSD1) regenerates
glucocorticoids from inactive 11-keto metabolites. Pharmacological inhibition or transgenic disruption
of 11 -HSD1 attenuates glucocorticoid action and increases insulin sensitivity. Increased ...
Cited by 49 - Related articles - BL Direct - All 3 versions

[CITATION] Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and …


RS Lindsay, A Tataranni, P Permana, DEW Livingstone … - J Clin Endocrinol Metab, 2003
Cited by 19 - Related articles

Down-Regulation of Adipose 11 {beta}-Hydroxysteroid Dehydrogenase Type 1 by …

- endojournals.org
NM Morton, L Ramage, JR Seckl - Endocrinology, 2004 - Endocrine Soc
The enzyme 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD-1) amplifies intracellular glucocorticoid
action in vivo. 11ß-HSD-1 activity is increased in adipose tissues of obese humans and genetically
obese rodents, providing a mechanistic basis for the similarities between metabolic ...
Cited by 45 - Related articles - BL Direct - All 5 versions

11 {beta}-Hydroxysteroid Dehydrogenase Activity in Hypothalamic Obesity

- endojournals.org
D Tiosano, I Eisentein, D Militianu, GP … - Journal of Clinical …, 2003 - Endocrine Soc
After extensive suprasellar operations for hypothalamic tumor removal, some patients develop
Cushing-like morbid obesity while they receive replacement doses of glucocorticoids. In this
study, we examined the hypothesis that target tissue conversion of inactive ...
Cited by 38 - Related articles - BL Direct - All 5 versions

Effects of the 11 {beta}-hydroxysteroid dehydrogenase inhibitor carbenoxolone on …

- endojournals.org
RC Andrews, O Rooyackers, BR Walker - Journal of Clinical …, 2003 - Endocrine Soc
Six diet-controlled nonobese diabetic patients with hemoglobin A 1c less than 8%, and six matched
controls participated in a double-blind, cross-over comparison of carbenoxolone (100 mg every
8 h, orally, for 7 d) and placebo. They were admitted overnight for infusions of insulin (as ...
Cited by 117 - Related articles - BL Direct - All 10 versions

Local and Systemic Impact of Transcriptional Up-Regulation of 11 {beta}- …

- endojournals.org
DJ Wake, E Rask, DEW Livingstone, S … - Journal of Clinical …, 2003 - Endocrine Soc
11ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11HSD1) is a potential target for pharmacological
inhibition in obesity and the metabolic syndrome. It catalyzes the conversion of inactive cortisone
to active cortisol, thereby amplifying activation of intracellular glucocorticoid receptors ...
Cited by 139 - Related articles - All 6 versions

Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in …

- endocrinology-journals.org [PDF] 
DE Livingstone, CJ Kenyon, BR Walker - Journal of Endocrinology, 2000 - Soc Endocrinology
Obesity has been associated with alterations in gluco- corticoid metabolism in both man and
rodents, but the underlying mechanisms remain undefined. We have previously reported
tissue-specific alterations in 11- hydroxysteroid dehydrogenase type 1 (11-HSD1) in ...
Cited by 53 - Related articles - BL Direct - All 5 versions

LACK OF MUTATIONS OF TYPE 1 11β-HYDROXYSTEROID DEHYDROGENASE …


E Caramelli, P Strippoli, T Di Giacomi, C … - Endocrine …, 2001 - informahealthcare.com
There is increasing evidence that in human obesity, particularly the abdominal phenotype, the
activity of the hypothalamic-pituitary-adrenal (HPA) axis is disregulated. At least two distinct alterations
have been reported: one is characterized by several neuroendocrine abnormalities and ...
Cited by 17 - Related articles - BL Direct - All 4 versions

Effect of chenodeoxycholic acid on 11β-hydroxysteroid dehydrogenase in various …


DJ Morris, GW Souness, SA Latif, MP Hardy, AS Brem - Metabolism, 2004 - Elsevier
Glucocorticoids are metabolized by isoforms of the enzyme 11β-hydroxysteroid dehydrogenase
(11β-HSD). There is some controversy concerning the bile acid, chenodeoxycholic acid
(CDCA), as a potential endogenously produced inhibitor of 11β-HSD. The present ...
Cited by 9 - Related articles - All 10 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google